Healthcare provider profile · identity verified

Robert E Primeau, MD

Internal Medicine · ISLAND POND, VT · NPI 1992769863

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	467	124
Losartan Potassium	Losartan Potassium	240	61
Amlodipine Besylate	Amlodipine Besylate	211	50
Metoprolol Succinate	Metoprolol Succinate	195	52
Lisinopril	Lisinopril	144	43
Metformin Hcl	Metformin Hcl	138	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	134	21
Levothyroxine Sodium	Levothyroxine Sodium	133	24
Omeprazole	Omeprazole	114	30
Hydrochlorothiazide	Hydrochlorothiazide	108	30
Tamsulosin Hcl	Tamsulosin Hcl	103	31
Pantoprazole Sodium	Pantoprazole Sodium	95	24
Furosemide	Furosemide	90	27
Celecoxib	Celecoxib	76	19
Prednisone	Prednisone	75	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	suppressed
Simvastatin	Simvastatin	74	19
Torsemide	Torsemide	73	17
Rosuvastatin Calcium	Rosuvastatin Calcium	71	19
Clonazepam	Clonazepam	68	14
Citalopram Hbr	Citalopram Hydrobromide	67	19
Duloxetine Hcl	Duloxetine Hcl	62	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	19
Albuterol Sulfate Hfa	Albuterol Sulfate	58	19
Eliquis	Apixaban	57	17
Allopurinol	Allopurinol	56	15
Gabapentin	Gabapentin	56	16
Metoprolol Tartrate	Metoprolol Tartrate	56	15
Spironolactone	Spironolactone	56	16
Trulicity	Dulaglutide	56	11
Famotidine	Famotidine	53	12
Lorazepam	Lorazepam	53	18
Oxycodone Hcl	Oxycodone Hcl	50	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	12
Atenolol	Atenolol	47	12
Finasteride	Finasteride	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	12
Farxiga	Dapagliflozin Propanediol	43	11
Fluoxetine Hcl	Fluoxetine Hcl	42	14
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Xarelto	Rivaroxaban	40	13
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Sertraline Hcl	Sertraline Hcl	38	11
Trazodone Hcl	Trazodone Hcl	38	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	37	suppressed
Glipizide Er	Glipizide	35	12
Myrbetriq	Mirabegron	35	suppressed
Ozempic	Semaglutide	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Potassium Chloride	Potassium Chloride	32	11
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	14
Donepezil Hcl	Donepezil Hcl	27	suppressed
Valsartan	Valsartan	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Oxycontin	Oxycodone Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Meloxicam	Meloxicam	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Potassium Citrate Er	Potassium Citrate	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Galantamine Er	Galantamine Hbr	14	suppressed
Glipizide	Glipizide	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error